2010 AnnuAl REpoRT - Ciberdem

More documents

Recommendations

Info

Principal Investigator index Álvarez, Carmen .................................................................................92 Balsinde, Jesús ..................................................................................54 Benito, Manuel ...................................................................................34 Blanco Vaca, Francisco ............................................................................56 Blázquez, Enrique ................................................................................94 Bosch, Fàtima ...................................................................................97 Burks, Deborah .................................................................................101 Carmena, Rafael .................................................................................59 Castaño, Luis ...................................................................................103 Correig, Xavier. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36 de Pablo, Flora .................................................................................107 Escobar Morreale, Héctor F ........................................................................62 Fernández Veledo, Sonia ...........................................................................38 Ferrer, Jorge ...................................................................................109 Gómez Foix, Anna Maria ...........................................................................40 Gomis, Ramon ..................................................................................111 Guinovart, Joan J ................................................................................42 Ibáñez, Lourdes .................................................................................65 Martín, Franz ...................................................................................115 Martínez Valverde, Ángela .........................................................................44 Masana, Lluís ...................................................................................69 Montanya, Eduard ...............................................................................118 Nadal, Angel ...................................................................................121 Novials, Anna ...................................................................................124 Serrano Ríos, Manuel .............................................................................73 Simó, Rafael ....................................................................................76 Soriguer, Federico ................................................................................81 Vallejo, Mario ...................................................................................127 Vázquez Carrera, Manuel ..........................................................................85 Vendrell, Joan J ..................................................................................87 Villanueva Peñacarrillo, María Luisa ..................................................................46 Zorzano, Antonio .................................................................................48 <strong>2010</strong> Annual Report 131
Keyword index* Beta-cell signal transduction. . . 34, 92, 97, 101, 115, 121 Bioinformatics . . . . . . . . . . . . . . . . . . . . . . 36 Biomarkers and Imaging. . . . . . . . . . . . . 36, 62, 69 Carbohydrate metabolism . . . . . . . . . . . . 40, 42, 48 Cardiac complications . . . . . . . . . . . . . . . . . . 85 Catecholamines . . . . . . . . . . . . . . . . . . . . 107 Clinical diabetes . . . . . . . . . . . . . . . .76, 103, 111 Clinical trial. . . . . . . . . . . . . . . . . . . . . . . 115 Cytokines. . . . . . . . . . . . . . . . 38, 44, 54, 65, 121 Endothelium . . . . . . . . . . . . . . . . . .69, 111, 124 Epidemiology. . . . . . . . . . . . . . . . . . . . . 73, 81 Exercise . . . . . . . . . . . . . . . . . . . . 38, 48, 124 Gastro-entero pancreatic factors . . . . . . . . . 92, 118 Gene therapy. . . . . . . . . . . . . . . . . . . . . . . 97 Genetics type 1 diabetes . . . . . . . . . . . . . . . 103 Genetics type 2 diabetes . . . . . . . 56, 69, 73, 94, 109 Genomics . . . . . . . . . . . . . . . . . . . 48, 73, 109 Glucose transport . . . . . . . . . . . . . . . . . . 38, 46 Hormone receptors . . . . . . . . . .44, 46, 94, 107, 121 Hormones (non-insulin), action . . . . . . . . . . . . 121 Incretins . . . . . . . . . . . . . . . . . . . . . . . 46, 94 Insulin action . . . . . . . . . . . . . . . . . . . 44, 48, 92 Insulin secretion . . . . . . . . . . . . . . . . . . . . 121 Insulin sensitivity and resistance 34, 38, 40, 42, 44, 46, 48, 59, 62, 65, 69, 85, 87, 92, 97, 101, 107, 121 Insulin synthesis . . . . . . . . . . . . . . . . . . . . 127 Insulin therapy . . . . . . . . . . . . . . . . . . . . . . 81 Islet amyloid polypeptide/amylin. . . . . . . . . . . . 124 Islet degeneration and damage . . 92, 101, 111, 115, 118, 124, 127 Islet development . . . . . . . . .107, 109, 111, 115, 127 Islet transplantation . . . . . . . . . . . . . . . . . . 118 Lipid metabolism. . . . . 38, 40, 46, 48, 54, 56, 59, 76, 85 Lipid signalling . . . . . . . . . . . . . . . . . . . . . . 54 Lipids, lipoproteins . . . . . . . . . . . . . . . . 36, 56, 85 Macrovascular disease . . . . . . . . . . . . . 34, 59, 69 Metabolic surgery . . . . . . . . . . . . . . . . . . . . 62 Metabolic syndrome . 42, 54, 56, 59, 65, 69, 73, 76, 81, 87 Metabolomics . . . . . . . . . . . . . . . . . . . . . . 36 Monogenic diabetes . . . . . . . . . . . . . . . . . . 103 Neuropathy-somatic . . . . . . . . . . . . . . . . . . . 97 Nutrigenomics . . . . . . . . . . . . . . . . . . . . . . 69 Obesity . . . . . . . . . . . . . . . . . . . . . . . . . 101 Oral pharmacological agents . . . . . . . 42, 48, 65, 103 Paediatrics . . . . . . . . . . . . . . . . . . . . . . . . 65 Pathogenic mechanisms . . . . . . . . . . . . . . . 34, 56 Phospholipases . . . . . . . . . . . . . . . . . . . . . 54 Polycystic ovary syndrome. . . . . . . . . . . . . . . . 62 PPAR . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 Prediction/prevention type 1 diabetes . . . . . . . . . 103 Prediction/prevention type 2 diabetes . . . . . . . . 81, 87 Pregnancy . . . . . . . . . . . . . . . . . . . . . . . . 87 Prevention of type 1 diabetes . . . . . . . . . . . . . . 73 Prevention of type 2 diabetes . . . . . . . . . . . . 65, 69 Proinsulin. . . . . . . . . . . . . . . . . . . . . . . . 107 Protein metabolism. . . . . . . . . . . . . . . . . . . . 48 Proteomics . . . . . . . . . . . . . . . . . . . . . . 62, 73 Retinopathy. . . . . . . . . . . . . . . 42, 44, 76, 97, 101 Stem cells . . . . . . . . . . . . . . 48, 94, 101, 115, 118 Transcription factors . . . . . . . . . 48, 85, 109, 124, 127 Weight regulation and obesity . .34, 44, 59, 76, 81, 87, 94, 111, 118 *Source: DIAMAP, Road Map for Diabetes Research in Europe. 132 CibeRdem
Page 1 and 2:
2010 Annual Report CIBERDEM Centro
Page 4 and 5:
Letter from the Scientific Director
Page 6 and 7:
Contents Prologue Research results
Page 8 and 9:
Research results Publications In 20
Page 10 and 11:
Project management Introduction The
Page 12 and 13:
Training programme Introduction The
Page 14 and 15:
Outreach activities CIBERDEM Fundra
Page 16 and 17:
More about CIBERDEM The Centro de I
Page 18 and 19:
Human Resources In 2010, CIBERDEM h
Page 20 and 21:
Transversal projects Di@bet.es Stud
Page 22 and 23:
Di@bet.es Study Introduction Attemp
Page 24 and 25:
CIBERDEM Projects Introduction CIBE
Page 26 and 27:
girls (girls born small for gestati
Page 28 and 29:
Biobank Introduction and objectives
Page 30 and 31:
Metabolomics Platform Introduction
Page 33 and 34:
Area 1 Insulin signalling and resis
Page 35 and 36:
Diabetes and cardiovascular Faculta
Page 37 and 38:
Metabolomics Platform Universitat R
Page 39 and 40:
Obesity, inflammation and insulin r
Page 41 and 42:
Mechanisms of control of glucose an
Page 43 and 44:
Metabolic engineering and diabetes
Page 45 and 46:
Molecular mechanisms of insulin res
Page 47 and 48:
Molecular characteristics, and acti
Page 49 and 50:
Heterogenic and polygenic diseases.
Page 51:
Principal Investigator: Antonio Zor
Page 54 and 55:
The research activity of this area
Page 56 and 57:
The cationic cluster of group IVA p
Page 58 and 59:
agent that affects the enterohepati
Page 60 and 61:
Dyslipidaemia, inflammation and end
Page 62 and 63:
Daño orgánico en la diabetes mell
Page 64 and 65:
Proteomic analysis of plasma in the
Page 66 and 67:
Prenatal growth restriction and sub
Page 68 and 69:
The effects of metformin on cardiov
Page 70 and 71:
Lipids and Arteriosclerosis Researc
Page 72 and 73:
Review Pitavastatin - from clinical
Page 74 and 75:
Diabetobe Hospital Clínico San Car
Page 76 and 77:
Scientific collaborations within CI
Page 78 and 79:
Atherosclerosis, 209, 201-205 (2010
Page 80 and 81:
Solvay, SA: 2008-2010 Principal Inv
Page 82 and 83: Endocrinology and Nutrition Service
Page 84 and 85: Prevención de la Diabetes mellitus
Page 86 and 87: Pharmacological targets in inflamma
Page 88 and 89: Diabetes and Metabolic Associated D
Page 90 and 91: Autonomous Community project Grup d
Page 92 and 93: Area 3 of CIBERDEM comprises thirte
Page 94 and 95: Escrivá F, Alvarez C J Mol Endocri
Page 96 and 97: Am J Physiol Endocrinol Metab, 298,
Page 98 and 99: Transgenic animal models and gene t
Page 100 and 101: Ayuso E, Mingozzi F, Bosch F Curr G
Page 102 and 103: Laboratory of Molecular Endocrinolo
Page 104 and 105: Hospital de Cruces Diabetes Researc
Page 106 and 107: Research grants International proje
Page 108 and 109: Proinsulin and tyrosine hydroxilase
Page 110 and 111: Genomic programming of beta cells I
Page 112 and 113: Diabetes and obesity: biopathology
Page 114 and 115: Utilidad de la ecografía arterial
Page 116 and 117: Islet cell and stem cell physiology
Page 118 and 119: in diabetic patients with chronic c
Page 120 and 121: Liraglutide versus sitagliptin for
Page 122 and 123: Unit of Cell Physiology and Nutriti
Page 124 and 125: National projects Efectos a corto y
Page 126 and 127: Altirriba J, Gasa R, Casas S, Ramí
Page 128 and 129: Transcriptional mechanisms of pancr
Page 131: Epilogue
Page 135 and 136: Association of selected ABC gene fa
Page 137 and 138: Leiter LA, Levitt NS, Mareev V, Mar
Page 139 and 140: Low body adiposity and high leptine
Page 141 and 142: Alvaro A, Rosales R, Masana L, Vall
Page 143 and 144: The apolipoprotein A5 (APOA5) gene
Page 145 and 146: www.ciberdem.org/annualreport CIBER
show all

2010 AnnuAl REpoRT - Ciberdem

Create successful ePaper yourself

Delete template?

Save as template?